candoxatrilat has been researched along with 106-dephenylalanyl-107-deglycyl-115-dearginyl-116-deglutamine-atriopeptin (103-126) in 2 studies
| Studies (candoxatrilat) | Trials (candoxatrilat) | Recent Studies (post-2010) (candoxatrilat) | Studies (106-dephenylalanyl-107-deglycyl-115-dearginyl-116-deglutamine-atriopeptin (103-126)) | Trials (106-dephenylalanyl-107-deglycyl-115-dearginyl-116-deglutamine-atriopeptin (103-126)) | Recent Studies (post-2010) (106-dephenylalanyl-107-deglycyl-115-dearginyl-116-deglutamine-atriopeptin (103-126)) |
|---|---|---|---|---|---|
| 46 | 10 | 1 | 8 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirk, JE; Moore, KP; Settle, SL; Taylor, SA; Unwin, RJ; Wilkins, MR | 1 |
| Kirk, JE; Wilkins, MR | 1 |
2 other study(ies) available for candoxatrilat and 106-dephenylalanyl-107-deglycyl-115-dearginyl-116-deglutamine-atriopeptin (103-126)
| Article | Year |
|---|---|
Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Topics: Animals; Arteriovenous Shunt, Surgical; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output, Low; Cyclic GMP; Cyclohexanecarboxylic Acids; Diuretics; Glomerular Filtration Rate; Lithium; Male; Natriuresis; Neprilysin; Peptide Fragments; Rats; Rats, Wistar | 1992 |
Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Cyclohexanecarboxylic Acids; Diuretics; Glomerular Filtration Rate; Infusions, Intravenous; Kidney; Ligands; Male; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Peptide Fragments; Rats; Rats, Wistar; Receptors, Atrial Natriuretic Factor; Sodium | 1993 |